Alkotinib Capsule in Patients With ALK-positive Non-small Cell Lung Cancer Previously Treated With Crizotinib
Clinical trial NCT04211922 · TERMINATED
Trial details
- NCT number
- NCT04211922
- Sponsor
- Suzhou Zelgen Biopharmaceuticals Co.,Ltd
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-21
- Primary completion
- 2022-10-11
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.